Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
10/2003
10/22/2003EP1353694A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/22/2003CN1125064C 3-pyridyl enantiomers and their use as analgesics
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003US20030191324 A N,O-bis(diphenylphosphino)-2-azetidine derivatives, a transition metal complex for use as hydrogenation catalysts
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191108 N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant staphylococcus aureus
10/09/2003US20030191106 Controlling gramnegative bacteria
10/09/2003US20030190743 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/02/2003WO2003080571A1 Process for producing azetidinone compounds
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003US20030187061 Antitumor agnets; antileukemia agents
10/01/2003EP1347987A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
09/2003
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077907A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1346981A1 PROCESS FOR SYNTHESIZING $g(b)-LACTAM
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345924A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345895A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003US20030176465 Cyclic amino acid derivatives
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003EP1049672B1 Azetidinecarboxamide derivatives for treating cns disorders
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/17/2003EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/09/2003US6617461 Process for preparation of optically active N-substituted azetidine-2-carboxylic acids
09/09/2003US6617451 Amidation of a racemic mixture of a cis-azetidinone having an unsaturated side group with an alkyl phenyl- or phenoxy-acetate in the presence of penicillin G amidase, optionally followed by hydrogenation.
09/09/2003US6617320 Protease inhibitor; anticoagulants
09/09/2003CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/03/2003EP1339723A1 Process and ester derivatives useful for preparation of cephalosporins
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
08/2003
08/28/2003US20030162961 Catalytic carbonylation of three and four membered heterocycles
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610708 Cyclic amino compounds
08/13/2003EP1333855A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP0971889B1 Process for synthesizing carbapenem intermediates
08/12/2003US6605716 By Reformatsky rearrangement of aldehydes, ketones, or imines in presence of zinc
08/07/2003US20030149280 Addition of base to an aqueous solvent containing an organic acid addition salt of an azetidine-2-carboxylic acid to displace organic acid addition salt, then protecting the N-group with a protecting agent
07/2003
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists
07/31/2003US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans
07/31/2003US20030144261 A cyclic peptide useful for treating eating disorder and diabetes
07/30/2003EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/30/2003CN1116298C Process for preparation of 2-halomethyl-penems and their use for preparation of antibacterial penems
07/29/2003US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants
07/24/2003WO2003016543A3 Enzymatic resolution of t-butyl taxane derivatives
07/24/2003US20030139614 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis
07/23/2003EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
07/17/2003WO2003057666A2 Inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv
07/17/2003US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
07/17/2003US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/16/2003EP1326824A1 Pharmaceutical compounds
07/16/2003CN1114637C Method of reactive amine catalysts for use in polyurethane formation
07/15/2003US6593482 Methods for preparing new taxoids and pharmaceutical compositions containing them
07/15/2003US6593474 Adrenergic blocking agents
07/15/2003US6593312 Cyclic α-amino-γ-hydroxyamide compounds
07/09/2003CN1113862C Arysulfonylamino hydroxamic acid derivs.
07/08/2003US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053431A2 Pharmaceutical compositions based on azetidine derivatives
07/03/2003WO2003026643A3 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
07/03/2003WO2002058734A3 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
07/03/2003US20030124683 Comprises hydrolase for N-benzylazetidine-2-carboxylic acid ester immolbilized on poroous divinylbenzene-styrene copolymer
07/03/2003CA2470443A1 Pharmaceutical compositions based on azetidine derivatives
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
07/02/2003EP1322609A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP1007511B1 Preparation of beta-methyl carbapenem intermediates
07/02/2003EP0759427B1 Process for producing halogenated beta-lactam compounds
06/2003
06/26/2003WO2003052113A1 Cyclisation process for the preparation of c-2 beta-lactam compounds
06/26/2003WO2003051314A2 Antibiotic compounds
06/26/2003US20030120096 Reacting racemic beta-lactam with lithium- 7-protected baccatin III- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 69